Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

BACKGROUND: Gastroesophageal adenocarcinoma (GOA) has poor clinical outcomes and lacks reliable blood markers. Here we present circulating tumour DNA (ctDNA) as an emerging biomarker. METHODS: Forty patients (17 palliative and 23 curative) were followed by serial plasma monitoring. Primary tumour DN...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Openshaw, Mark R., Suwaidan, Ali Abdulnabi, Ottolini, Barbara, Fernandez-Garcia, Daniel, Richards, Cathy J., Page, Karen, Guttery, David S., Thomas, Anne L., Shaw, Jacqui A.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7555811/
https://ncbi.nlm.nih.gov/pubmed/32719550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-1002-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars